COMMONS

Tobacco companies and academics questioned on e-cigarettes

22 February 2018

The Science and Technology Committee continues its inquiry on e-cigarettes. This Session hears from four tobacco companies about their own research on the health effect of e-cigarette devices and the second panel examines the toxicity of e-cigarettes, and how puffing behaviours, settings of the device or other factors may affect the toxicity.

Witnesses

Tuesday 27 February 2018, Wilson Room, Portcullis House

At 9.30am

  • Dr Ian Jones, Vice President, Reduced-Risk Products, Japan Tobacco International
  • Dr Chris Proctor, Chief Scientific Officer, British American Tobacco
  • Dr Moira Gilchrist, Vice President, Scientific and Public Communications, Philip Morris Limited
  • Dr Grant O’Connell, Regulatory and Scientific Affairs, Fontem Ventures

At 10.40am

  • Professor David Harrison, Chair of the UK Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment (COC)
  • Dr Lynne Dawkins, Associate Professor, London Southbank University Behavioural Science Centre

The Committee held its first session on e-cigarettes on the 9 January 2018, hearing from academics about the current research findings around the harmfulness around e-cigarettes, its potential as a smoking cessation tool and its possible “gate way” effect on smoking.

Further information

Image: iStockphoto

Share this page